Literature DB >> 35355013

Human distal airways contain a multipotent secretory cell that can regenerate alveoli.

Maria C Basil1,2, Fabian L Cardenas-Diaz1,2, Jaymin J Kathiriya3, Michael P Morley1,2,4, Justine Carl1,2, Alexis N Brumwell3, Jeremy Katzen1,2, Katherine J Slovik1,2,4, Apoorva Babu1,2,4, Su Zhou1,2, Madison M Kremp1,2, Katherine B McCauley5, Shanru Li1,2, Joseph D Planer1,2, Shah S Hussain6, Xiaoming Liu7, Rebecca Windmueller2,8, Yun Ying1,2, Kathleen M Stewart1,2, Michelle Oyster1, Jason D Christie1,2, Joshua M Diamond1, John F Engelhardt7, Edward Cantu2,9, Steven M Rowe6, Darrell N Kotton5,10, Harold A Chapman3,11, Edward E Morrisey12,13,14.   

Abstract

The human lung differs substantially from its mouse counterpart, resulting in a distinct distal airway architecture affected by disease pathology in chronic obstructive pulmonary disease. In humans, the distal branches of the airway interweave with the alveolar gas-exchange niche, forming an anatomical structure known as the respiratory bronchioles. Owing to the lack of a counterpart in mouse, the cellular and molecular mechanisms that govern respiratory bronchioles in the human lung remain uncharacterized. Here we show that human respiratory bronchioles contain a unique secretory cell population that is distinct from cells in larger proximal airways. Organoid modelling reveals that these respiratory airway secretory (RAS) cells act as unidirectional progenitors for alveolar type 2 cells, which are essential for maintaining and regenerating the alveolar niche. RAS cell lineage differentiation into alveolar type 2 cells is regulated by Notch and Wnt signalling. In chronic obstructive pulmonary disease, RAS cells are altered transcriptionally, corresponding to abnormal alveolar type 2 cell states, which are associated with smoking exposure in both humans and ferrets. These data identify a distinct progenitor in a region of the human lung that is not found in mouse that has a critical role in maintaining the gas-exchange compartment and is altered in chronic lung disease.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35355013      PMCID: PMC9297319          DOI: 10.1038/s41586-022-04552-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  54 in total

1.  Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures.

Authors:  E R WEIBEL; D M GOMEZ
Journal:  Science       Date:  1962-08-24       Impact factor: 47.728

2.  Global and regional trends in COPD mortality, 1990-2010.

Authors:  Peter G J Burney; Jaymini Patel; Roger Newson; Cosetta Minelli; Mohsen Naghavi
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

3.  Design of peripheral airways for efficient gas exchange.

Authors:  Ewald R Weibel; Bernard Sapoval; Marcel Filoche
Journal:  Respir Physiol Neurobiol       Date:  2005-08-25       Impact factor: 1.931

4.  Site and nature of airway obstruction in chronic obstructive lung disease.

Authors:  J C Hogg; P T Macklem; W M Thurlbeck
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

5.  Cell number and distribution in human and rat airways.

Authors:  R R Mercer; M L Russell; V L Roggli; J D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  1994-06       Impact factor: 6.914

Review 6.  Cellular crosstalk in the development and regeneration of the respiratory system.

Authors:  Jarod A Zepp; Edward E Morrisey
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06-19       Impact factor: 94.444

7.  The proximal border of the human respiratory unit, as shown by scanning and transmission electron microscopy and light microscopical cytochemistry.

Authors:  A A ten Have-Opbroek; C J Otto-Verberne; J A Dubbeldam; J H Dÿkman
Journal:  Anat Rec       Date:  1991-03

Review 8.  Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function.

Authors:  Brigid L M Hogan; Christina E Barkauskas; Harold A Chapman; Jonathan A Epstein; Rajan Jain; Connie C W Hsia; Laura Niklason; Elizabeth Calle; Andrew Le; Scott H Randell; Jason Rock; Melinda Snitow; Matthew Krummel; Barry R Stripp; Thiennu Vu; Eric S White; Jeffrey A Whitsett; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2014-08-07       Impact factor: 24.633

Review 9.  Bronchiolar disorders.

Authors:  Jay H Ryu; Jeffrey L Myers; Stephen J Swensen
Journal:  Am J Respir Crit Care Med       Date:  2003-12-01       Impact factor: 21.405

Review 10.  The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future.

Authors:  Maria C Basil; Jeremy Katzen; Anna E Engler; Minzhe Guo; Michael J Herriges; Jaymin J Kathiriya; Rebecca Windmueller; Alexandra B Ysasi; William J Zacharias; Hal A Chapman; Darrell N Kotton; Jason R Rock; Hans-Willem Snoeck; Gordana Vunjak-Novakovic; Jeffrey A Whitsett; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2020-04-02       Impact factor: 24.633

View more
  7 in total

Review 1.  Exploiting the potential of lung stem cells to develop pro-regenerative therapies.

Authors:  Robert E Hynds
Journal:  Biol Open       Date:  2022-10-14       Impact factor: 2.643

Review 2.  What Can an Organ-on-a-Chip Teach Us About Human Lung Pathophysiology?

Authors:  Haiqing Bai; Donald E Ingber
Journal:  Physiology (Bethesda)       Date:  2022-06-06

Review 3.  Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF).

Authors:  Paola Confalonieri; Maria Concetta Volpe; Justin Jacob; Serena Maiocchi; Francesco Salton; Barbara Ruaro; Marco Confalonieri; Luca Braga
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 4.  Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis.

Authors:  Alejandro Egea-Zorrilla; Laura Vera; Borja Saez; Ana Pardo-Saganta
Journal:  Cells       Date:  2022-08-20       Impact factor: 7.666

Review 5.  New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome.

Authors:  Marilia Sanches Santos Rizzo Zuttion; Sarah Kathryn Littlehale Moore; Peter Chen; Andrew Kota Beppu; Jaime Lynn Hook
Journal:  Biomolecules       Date:  2022-09-10

6.  CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells.

Authors:  Rhiannon B Werder; Tao Liu; Kristine M Abo; Jonathan Lindstrom-Vautrin; Carlos Villacorta-Martin; Jessie Huang; Anne Hinds; Nathan Boyer; Esther Bullitt; Marc Liesa; Edwin K Silverman; Darrell N Kotton; Michael H Cho; Xiaobo Zhou; Andrew A Wilson
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

7.  Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.

Authors:  Shah S Hussain; Yvonne J K Edwards; Emily Falk Libby; Denise Stanford; Stephen A Byzek; Don D Sin; Merry-Lynn McDonald; S Vamsee Raju; Steven M Rowe
Journal:  Respir Res       Date:  2022-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.